DTB select: No benefit of faecal microbiota transplantation for IBS-D

Summary and context is provided on a double-blind randomised placebo-controlled crossover study (n=48) which found that three days of oral faecal microbiota transplantation capsules did not show a benefit over placebo in reducing symptoms of diarrhoea-predominant IBS.

Source:

Drug and Therapeutics Bulletin